Showing results (2501-2510 of 13,857) with videos related to

Sort By:
Pageof 1,386
American Heart Journal|June 5, 2025
Conduction system pacing vs biventricular resynchronization in heart failure with reduced ejection fraction and left bundle branch block: Rationale and design of the PhysioSync-HF TrialAndré Zimerman, Alexander Dal Forno, Luis E Rohde, et al.
American Heart Journal|May 28, 2025
Design and rationale of the VICTORION-Difference study: A phase 4 randomized, double-blind, placebo-controlled clinical trial to assess inclisiran's early efficacy, safety, tolerability, as well as its impact on quality of life in individuals with hypercholesterolemiaUlf Landmesser, Ulrich Laufs, Ulrike Schatz, et al.
American Heart Journal|June 5, 2025
Rationale, design, and baseline characteristics of the virtual care to improve heart failure outcomes (VITAL-HF) trialMirza S Khan, Andrew J Sauer, Cynthia L Green, et al.
American Heart Journal|November 3, 2025
Veteran voices on the MISSION act: Satisfaction and care preferences following community referral for structural heart disease carePal Shah, Atreya Mishra, Krupa Patel, et al.
American Heart Journal|October 5, 2025
Effect of opt-in versus opt-out framing on trial recruitment: a study within a trial of the GAMEPAD randomized trialTayyab Shah, Samantha Coratti, David Farraday, et al.
American Heart Journal|October 2, 2025
Mavacamten in symptomatic adolescent patients with obstructive hypertrophic cardiomyopathy: design of the phase 3 SCOUT-HCM trialJoseph Rossano, Charles Canter, Cordula Wolf, et al.
American Heart Journal|July 4, 2025
Early support in patients with St-segment elevation myocardial infarction complicated by shock. Design of exception from informed consent processes in recover iv trialKaren N Adams, Neal W Dickert, Gregg W Stone, et al.
American Heart Journal|February 4, 2026
Study design for an emulated trial of a two arm, parallel, stratified, adaptive, RCT of CABG versus PCI in people requiring myocardial revascularisation at high risk (High-Risk REVASC)Weiqi Liao, Muhammad Rashid, Cassandra L Brookes, et al.
American Heart Journal|February 7, 2026
Probabilities of treatment effects in complete or culprit-only revascularization for NSTEMI: a Bayesian re-analysis of the SLIM trialSamuel Heuts, Tobias F S Pustjens, Árpad Lux, et al.
American Heart Journal|April 14, 2025
Rationale and design of the TADCLOT trial: A double blind randomized controlled trial comparing twice a day clopidogrel vs ticagrelor in reducing major cardiac events in patients with acute STEMI undergoing primary percutaneous coronary interventionAbdul Hakeem, Jehangir Ali Shah, Rajesh Kumar, et al.
Pageof 1,386